Piver Type II vs. Type III Hysterectomy in the Treatment of Early-Stage Cervical Cancer: Midterm Follow-up Results of a Randomized Controlled Trial

Introduction: With the expansion of value-based medicine, we explore whether using type III hysterectomy to treat low-risk, early-stage cervical cancer constitutes overtreatment. In present study, we evaluate the midterm safety and postoperative quality of life of patients who underwent type II hyst...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Hengzi, Cao, Dongyan, Shen, Keng, Yang, Jiaxin, Xiang, Yang, Feng, Fengzhi, Wu, Lingying, Zhang, Zhenyu, Ling, Bin, Song, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280766/
https://www.ncbi.nlm.nih.gov/pubmed/30555800
http://dx.doi.org/10.3389/fonc.2018.00568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280766/
https://www.ncbi.nlm.nih.gov/pubmed/30555800
http://dx.doi.org/10.3389/fonc.2018.00568

Ejemplares similares